October 20, 2022

New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).

August 18, 2022

New research from the University of Cincinnati,examines the barriers as well as those that are helpful in the prevention and treatment of COVID-19 in Latinx families in Cincinnati. Researchers identified primary barriers that include insecurities in food, jobs and housing and immigration. Key facilitators included having trusted messengers of health-related information.

August 25, 2022

One of the major roadblocks in the fight against the spread of COVID-19 in the early days of the pandemic was people refusing to get vaccinated against the virus. New research at UC examines that vaccine hesitancy and provides key insights into the behaviors and perceptions of the U.S. population during a critical time of the COVID-19 pandemic, just as vaccines were becoming more available.